Description
VITROS® XT Systems embrace DIGITAL CHEMISTRY™ and are powered by a new digital reflectometer, connecting your labs ecosystem better than ever before, driving your efficiency, productivity and improving the quality of care you can provide to your patients.
DIGITAL CHEMISTRY™
The digital chemistry behind Ortho’s VITROS® XT 7600 is based on three enabling technologies:
- Dry slide technology. Unlike traditional wet chemistry systems, which require highly purified water and complex plumbing systems to operate, Ortho’s proprietary dry slide technology does not require water to run. This eliminates the risk that poor water quality could impact test results.
- MicroSlide. A full testing environment on a postage-stamp-sized piece of film enables precise and accurate testing in a waterless environment.
- Digital imaging technology. Advanced optics glean significantly more information from testing than has been possible to date, enabling better precision and powerful data intelligence functions in the lab.
In addition, Ortho’s VITROS® XT 7600 increases productivity, with less patient blood sample required, by introducing multi-test processing – the potential to offer two tests per slide instead of one — to clinical chemistry. With XT MicroSlides1, the instrument will provide the ability to pair tests that are frequently ordered for the same patient so they can be run simultaneously. This saves time and space in the lab, and reduces the amount of blood needed for testing, an important advantage for vulnerable patients or those with venous access issues.
Lab Benefits
- Market leading F.P.Y. of 96.5%
- Reduced patient sample size to 3.8 microL
- Improved interference detection
- Enables XT Microslide technology
- Improves our proven proprietary technologies
- Future-readies your lab for the challenges of tomorrow*
* Compared to wet technologies
more information at the official website
Technologies
VITROS® MicroSlide Technology
How it works: VITROS® MicroSlide Technology offers an entire integrated test environment on a thin piece of film. Spreading, masking, scavenger, and reagent layers are discretely combined on one postage-stamp-sized slide to produce first-class precision and accuracy. When plasma, serum, urine, or cerebrospinal fluid come into contact with these dry chemical layers, a spectral reaction occurs, which can be measured by the system. This layered dry slide technology enables separate reaction domains—maximizing each step for exceptional assay performance.
What it offers your lab:
- Excellent assay performance while reducing costs
- High-quality results in diverse patient settings
- Proven methodologies referenced to industry standards, including:
- Wide dynamic ranges
- Small sample size
- Reduced substance interference
- 95% reportable results efficiency1
- Minimal operator interventions
- Maximum ease of use
- Consistent results over time and across the world
- No reagent preparation or waste
- No water, plumbing, or drains
- No electrodes to maintain
- No pumps or tubing
- Up to 12–24 month shelf life
- Exceptional calibration stability1
- Minimal storage space
VITROS® MicroTip Technology
How it works: VITROS® MicroTip Technology utilizes single-use disposable tips and closed reagent packs to eliminate the risk of sample carryover and reagent-to-reagent contamination, and to extend onboard reagent stability. It requires no drains, plumbing, fixed probes, or mixing assemblies to perform therapeutic and abused drug testing, specific proteins, and user-defined applications.
What it offers your lab:
- Liquid, ready-to-use reagents that need no preparation*
- Refrigerated storage to maximize on-system stability
- Reagent packs that are automatically opened and closed
- Limits contamination, evaporation, and reagent cross-talk
- Enhances reagent and calibration stability
- Helps ensure quality results
- Contains costs by reducing reagent waste
- Single-use sample and reagent tips to address carryover concerns
- Single-use reaction cuvettes for greater precision and accuracy
- *Except for caffeine reagents
- Offers 3-point cuvette read
- Detects bubbles and other imperfections
- Avoids erroneous result reporting
- Allows greater flexibility for setting up user-defined assays
VITROS® MicroWell Technology
How it works: VITROS® MicroWell Technology maximizes binding capacities with a unique coating process. And proprietary Enhanced Chemiluminesce Detection Technology provides wide dynamic ranges and exceptional immunoassay precision and accuracy across multiple disease states. This means fewer unnecessary dilutions, repeats, and redraws—delivering better patient care and greater laboratory efficiencies.
What it offers your lab:
- Excellent assay sensitivity and precision
- Capability for small sample volumes
- Minimal waste with a small MicroWell
- Enhanced Chemiluminescent Detection Technology that delivers1,2:
- Improved signal (light) output, even at low analyte concentrations, for better detection*
- Broad dynamic range*
VITROS® MicroSensor Technology
How it works: VITROS® MicroSensor Technology detects endogenous interferences and flags affected results without the use of reagents or extra consumables
What it offers your lab:
- Detection and flagging of results affected by common interferences (hemolysis, icterus, and turbidity)
- No reagents or additional sample volume requirements
- An analysis time of <1 second
- No impact on system workflow
VITROS® Intellicheck® Technology
How it works: Based on proven, innovative, and patented technologies, including advanced processing features, VITROS® Intellicheck® Technology monitors, verifies, and documents diagnostic checks throughout sample and assay processing for accurate and efficient result reporting
What it offers your lab:
- SMART Metering featuring single-use tips and Save-the-Sample Clot Detection Management and bubble detection to avoid reporting erroneous results
- MicroSensor Technology that flags all results affected by common interferences with no reagents, additional sample volume, or impact on throughput
- IntelliReport™ that provides full traceability, operator notification, and real-time exception documentation
- Integrated process control that verifies the integrity of the sample processed and results reported
COVID-19
Now more than ever, we see the critical role the lab and their staff play in helping clinicians quickly and accurately diagnose and triage patients within the overburdened hospitals during this pandemic.
For patients afflicted with the SARS-CoV-2 virus, information provided by the lab can help assess the severity of the infection and monitor therapeutic interventions. Anti-SARS-CoV-2 antibody tests can help evaluate the body’s immune response to the disease.
https://www.orthoclinicaldiagnostics.com/en-us/home/ortho-covid-19-answer
